Published by Oxford University Press on behalf of the International Epidemiological Association © The Author 2008; all rights reserved.
Commentary: Collaboration between industry-based and academic epidemiologists
Worldwide Epidemiology Department, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, USA.
*Corresponding author. Worldwide Epidemiology Department, GlaxoSmithKline, 5 Moore Drive, Research Triangle Park, North Carolina, USA. E-mail: alice.d.white@gsk.com
Accepted 25 July 2007
| The first 10% of the full text of this article appears below. |
The article by Neil Pearce in this issue, ‘Corporate influences on epidemiology’1 questions the role and practices of epidemiologists working with industry. The author argues that ‘In many instances, academics have accepted industry funding which has not been acknowledged, and only the academic affiliations of the company-funded consultants have been listed’. He believes that this and other unethical practises are major threats to the integrity of epidemiological research. Although the article is addressed primarily to academic epidemiologists who consult with industry, there are a number of issues raised in
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  G. Davey Smith Big business, big science? Int. J. Epidemiol., February 1, 2008; 37(1): 1 - 3. [Full Text] [PDF]
|
|
|
|
|
|
N. Pearce Response: The distribution and determinants of epidemiologic research Int. J. Epidemiol., February 1, 2008; 37(1): 65 - 68. [Full Text] [PDF]
|
|